As we step into February 2025, global markets are navigating a complex landscape marked by fluctuating corporate earnings and geopolitical tensions, with the Federal Reserve maintaining steady ...
The increasing global prevalence of cancer is fueling the demand for peptide-drug conjugates as targeted therapies, providing improved effectiveness and lower systemic toxicity than conventional ...